Regional citrate anticoagulation for continuous renal replacement therapy in newborns

Regional citrate anticoagulation for continuous renal replacement therapy in newborns

BackgroundRegional citrate anticoagulant (RCA) is recommended as the preferred anticoagulant regimen for continuous renal replacement therapy (CRRT) in adults; however, it is rarely reported in neonates due to concerns associated with their immature liver. Few studies have reported on the use of RCA...

Full description

Bibliographic Details
Main Authors:	Haixia Huang, Xing Deng, Ke Bai, Chengjun Liu, Feng Xu, Hongxing Dang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Pediatrics
Subjects:	citrate accumulation continuous renal replacement therapy newborns regional citrate anticoagulation critically ill
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2023.1089849/full

Similar Items

Novel blood product transfusion regimen to prevent clotting and citrate accumulation during continuous renal replacement therapy with regional citrate anticoagulation in children
by: Yuelin Sun, et al.
Published: (2023-06-01)

Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction
by: Matthias Klingele, et al.
Published: (2017-11-01)

Construction and validation of a prediction model for the risk of citrate accumulation in patients with hepatic insufficiency receiving continuous renal replacement therapy with citrate anticoagulation
by: Quxia Hong, et al.
Published: (2024-01-01)

Clinical application of regional citrate anticoagulation for continuous renal replacement therapy in children with liver injury
by: Fang Hu, et al.
Published: (2022-10-01)

Clinical application of regional citrate anticoagulation for membrane-based therapeutic plasma exchange in children with liver failure
by: Jun Hu, et al.
Published: (2023-10-01)

Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis
by: Wei Zhang, et al.
Published: (2019-01-01)

Adverse events with regional citrate anticoagulation versus heparin anticoagulation during continuous renal replacement therapy: a systematic review and trial sequential analysis
by: Min-min Wang, et al.
Published: (2023-10-01)

A Rare Case of Severe Metabolic Alkalosis with Unusual Hyperproteinemia Treated with Continuous Renal Replacement Therapy and Regional Citrate Anticoagulation
by: Vojtěch Matoušek, et al.
Published: (2018-08-01)

Complications of regional citrate anticoagulation: accumulation or overload?
by: Antoine G. Schneider, et al.
Published: (2017-11-01)

Management of regional citrate anticoagulation for continuous renal replacement therapy: guideline recommendations from Chinese emergency medical doctor consensus
by: Shu-Yuan Liu, et al.
Published: (2023-05-01)

Comparison of Citrate and Heparin for Continuous Renal Replacement Therapy in Pediatric Intensive Units
by: Edin Botan, et al.
Published: (2023-12-01)

Simple citrate anticoagulation protocol for low flux haemodialysis
by: Eng Kuang Lim, et al.
Published: (2018-01-01)

Nafamostat mesylate versus regional citrate anticoagulation for continuous renal replacement therapy in patients at high risk of bleeding: a retrospective single-center study
by: Dan Liu, et al.
Published: (2024-01-01)

Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy: Is Metabolic Fear the Enemy of Logic? A Systematic Review and Meta-Analysis of Randomised Controlled Trials
by: Rita Jacobs, et al.
Published: (2023-05-01)

Regional citrate anticoagulation (RCA) in critically ill patients undergoing renal replacement therapy (RRT): expert opinion from the SIAARTI-SIN joint commission
by: Valentina Pistolesi, et al.
Published: (2023-03-01)

Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney Injury
by: De-Lin Liu, et al.
Published: (2016-01-01)

Applying Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy for Acute Kidney Injury Patients with Acute Liver Dysfunction: a Retrospective Observational Study
by: Ying Yu, et al.
Published: (2018-07-01)

Unapparent systemic effects of regional anticoagulation with citrate in continuous renal replacement therapy: a narrative review
by: Willem Boer, et al.
Published: (2023-03-01)

Safety and Metabolic Tolerance of Citrate Anticoagulation in Critically Ill Polytrauma Patients with Acute Kidney Injury Requiring an Early Continuous Kidney Replacement Therapy
by: Filippo Mariano, et al.
Published: (2023-09-01)

The effect of regional citrate anti-coagulation on the coagulation system in critically ill patients receiving continuous renal replacement therapy for acute kidney injury - an observational cohort study
by: Richard Fisher, et al.
Published: (2017-10-01)

Monocytes as Targets for Immunomodulation by Regional Citrate Anticoagulation
by: Giovana Seno Di Marco, et al.
Published: (2024-03-01)

Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis
by: Ilan Lenga, et al.
Published: (2019-12-01)

Safety of Citrate Anticoagulation in CKRT: Monocentric Experience of a Dynamic Protocol of Calcium Monitoring
by: Federico Nalesso, et al.
Published: (2023-08-01)

Use of regional citrate anticoagulation with medium cut-off membrane: pilot report
by: Marija Malgaj Vrečko, et al.
Published: (2022-10-01)

Comparison between regional citrate anticoagulation and heparin for intermittent hemodialysis in ICU patients: a propensity score-matched cohort study
by: Christophe Leroy, et al.
Published: (2021-01-01)

Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study
by: Richard Fisher, et al.
Published: (2022-03-01)

Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
by: Paul Köglberger, et al.
Published: (2021-04-01)

Analysis of Leukocyte Recruitment in Continuous Veno-Venous Hemofiltration with Regional Citrate vs. Systemic Heparin Anticoagulation
by: Andreas Margraf, et al.
Published: (2022-06-01)

A novel citrate-based protocol versus heparin anticoagulation for sustained low-efficiency dialysis in the ICU: safety, efficacy, and cost
by: Ming Wen, et al.
Published: (2018-04-01)

Regional citrate anticoagulation for replacement therapy in patients with liver failure: A systematic review and meta-analysis
by: Bo Peng, et al.
Published: (2023-02-01)

Rapid calcium loss may cause arrhythmia in hemofiltration with regional citrate anticoagulation: a case report
by: Buyun Wu, et al.
Published: (2018-06-01)

Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk
by: Jing Jiao, et al.
Published: (2023-12-01)

Delay in onset of metabolic alkalosis during regional citrate anti-coagulation in continous renal replacement therapy with calcium-free replacement solution
by: See Kay, et al.
Published: (2009-01-01)

Molecular Mechanism of Citrate Efflux by the Mitochondrial Citrate Transporter CT in Filamentous Fungus Mucor circinelloides WJ11
by: Wu Yang, et al.
Published: (2021-05-01)

Continuous renal replacement therapy in COVID-19—associated AKI: adding heparin to citrate to extend filter life—a retrospective cohort study
by: Eduardo de Oliveira Valle, et al.
Published: (2021-08-01)

Regional Citrate Anticoagulation and Systemic Anticoagulation during Pediatric Continuous Renal Replacement Therapy: A Systematic Literature Review
by: Emanuele Buccione, et al.
Published: (2022-05-01)

Regional citrate anticoagulation “non-shock” protocol with pre-calculated flow settings for patients with at least 6 L/hour liver citrate clearance
by: Lenar Yessayan, et al.
Published: (2021-07-01)

Diethyl citrate and sodium citrate reduce the cytotoxic effects of nanosized hydroxyapatite crystals on mouse vascular smooth muscle cells
by: Zhang CY, et al.
Published: (2017-11-01)

Anticoagulation during continuous renal replacement therapy: An update
by: Aslanidis Theodoros, et al.
Published: (2019-01-01)

Effects of pH and concentration of sodium citrate anticoagulant on platelet aggregation measured by light transmission aggregometry induced by adenosine diphosphate
by: Ksenia Germanovich, et al.
Published: (2018-01-01)